The British Society of Gastroenterology IBD section and IBD Clinical Research Group has released a position statement on SARS-CoV-2 vaccination guidelines for patients with IBD.
Investigators analyzed the impact of the COVID-19 pandemic on number of GI procedures performed and new cancer diagnoses.
Investigators compared the efficacy of open-label placebo with double-blind placebo in the treatment of patients with IBS.
The benefit of a combination of dupilumab treatment with a short course of narrow-band ultraviolet B phototherapy for patients with severe atopic dermatitis was quantified.
